| GDF15 quartiles | p for trend a | |||
---|---|---|---|---|---|
Q1 (n = 1080) | Q2 (n = 1079) | Q3 (n = 1080) | Q4 (n = 1079) | ||
GDF-15 (AU) | 8.09 ± 0.26 | 8.56 ± 0.11 | 8.90 ± 0.14 | 9.47 ± 0.38 | < 0.0001 |
Age (years) | 54.6 ± 5.60 | 56.6 ± 5.70 | 58.6 ± 5.50 | 60.1 ± 5.60 | < 0.0001 |
Sex (male, %) | 426 (39.4) | 425 (39.4) | 426 (39.4) | 425 (39.4) | 0.99 |
Waist circumference (cm) | 81.6 ± 11.6 | 82.3 ± 12.3 | 83.5 ± 12.9 | 85.3 ± 13.5 | < 0.001 |
Fasting glucose (mmol/L) b | 4.80 (4.60-5.20) | 4.90 (4.60-5.20) | 4.90 (4.60-5.30) | 5.00 (4.70-5.40) | < 0.0001 |
Systolic blood pressure (mmHg) | 136.1 ± 16.7 | 140 ± 18.9 | 142.4 ± 19.3 | 144.7 ± 19.3 | < 0.0001 |
Diastolic blood pressure (mmHg) | 85.6 ± 8.60 | 86.6 ± 9.40 | 86.9 ± 9.50 | 87.5 ± 9.60 | < 0.001 |
Low-density lipoprotein cholesterol (mmol/L) | 4.09 ± 0.94 | 4.05 ± 0.94 | 4.25 ± 0.99 | 4.24 ± 1.03 | < 0.001 |
C-reactive protein (mg/L) b | 1.00 (0.50-1.90) | 1.10 (0.60-2.30) | 1.40 (0.70-2.90) | 1.90 (1.00-4.20) | < 0.0001 |
eGFR (mL/min/1.73 m2) | 94.3 ± 12.5 | 90.5 ± 12.2 | 88.1 ± 12.5 | 83.8 ± 14.5 | < 0.0001 |
N-terminal pro-B-type natriuretic peptide (AU) | − 0.31 ± 0.92 | −0.06 ± 0.94 | 0.09 ± 0.97 | 0.26 ± 1.03 | < 0.0001 |
High alcohol consumption (%) | 42 (3.89) | 37 (3.43) | 34 (3.15) | 34 (3.15) | 0.31 |
Smoking n (%) | Â | Â | Â | Â | Â |
Never | 528 (48.9) | 458 (42.4) | 420 (38.9) | 369 (34.2) | < 0.0001 |
Former | 451 (41.8) | 428 (39.7) | 410 (38.0) | 340 (31.5) | < 0.0001 |
Current | 101 (9.35) | 193 (17.9) | 250 (23.1) | 370 (34.3) | < 0.0001 |
Anti-hypertensive medication (%) | 121 (11.2) | 150 (13.9) | 186 (17.2) | 235 (21.8) | < 0.0001 |
Diabetes (%) | 40 (3.70) | 59 (5.47) | 81 (7.50) | 144 (13.3) | < 0.0001 |
Cardiovascular disease (%) | 9 (0.83) | 22 (2.04) | 28 (2.59) | 43 (3.99) | < 0.0001 |